IRIS
SCOTTO, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.642
EU - Europa 2.005
NA - Nord America 1.968
SA - Sud America 404
AF - Africa 81
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.845
SG - Singapore 1.326
RU - Federazione Russa 1.110
CN - Cina 691
IT - Italia 360
BR - Brasile 326
VN - Vietnam 201
HK - Hong Kong 199
DE - Germania 136
NL - Olanda 123
CA - Canada 63
GB - Regno Unito 59
IN - India 58
KR - Corea 46
FI - Finlandia 45
FR - Francia 39
MX - Messico 39
AR - Argentina 37
PL - Polonia 31
BD - Bangladesh 22
ZA - Sudafrica 22
CI - Costa d'Avorio 18
ES - Italia 17
IE - Irlanda 17
ID - Indonesia 16
JP - Giappone 15
UA - Ucraina 15
CO - Colombia 14
IQ - Iraq 14
AT - Austria 11
EG - Egitto 11
SE - Svezia 11
EC - Ecuador 9
LT - Lituania 9
MA - Marocco 9
AE - Emirati Arabi Uniti 7
JM - Giamaica 6
SA - Arabia Saudita 6
CL - Cile 5
PK - Pakistan 5
UZ - Uzbekistan 5
AU - Australia 4
BE - Belgio 4
DZ - Algeria 4
NZ - Nuova Zelanda 4
TR - Turchia 4
UY - Uruguay 4
VE - Venezuela 4
CH - Svizzera 3
IR - Iran 3
LV - Lettonia 3
OM - Oman 3
TN - Tunisia 3
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
CV - Capo Verde 1
DM - Dominica 1
EU - Europa 1
HN - Honduras 1
JO - Giordania 1
KW - Kuwait 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
PE - Perù 1
PF - Polinesia Francese 1
PH - Filippine 1
PW - Palau 1
PY - Paraguay 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.107
Salva come PNG Salva come JPEG
Città #
Singapore 639
Ashburn 297
Moscow 284
Hefei 272
Hong Kong 199
Beijing 169
Chandler 152
Naples 143
Santa Clara 112
Los Angeles 100
Amsterdam 97
Ho Chi Minh City 73
New York 61
Dallas 53
Munich 49
Seoul 45
Hanoi 41
São Paulo 40
Millbury 30
Redondo Beach 30
Boston 29
Warsaw 27
Ottawa 26
Lawrence 25
Seattle 25
Des Moines 24
Napoli 24
San Jose 24
Turku 23
Boardman 22
Rome 21
Nuremberg 20
Buffalo 19
Brooklyn 17
Montreal 17
The Dalles 17
Frankfurt am Main 16
Orem 16
Tokyo 15
Houston 14
Querétaro 14
Chennai 13
Nanjing 12
Poplar 12
Wilmington 12
Baghdad 11
Chicago 11
Mexico City 11
Pozzuoli 11
Princeton 10
San Francisco 10
Stockholm 10
Atlanta 9
London 9
Rio de Janeiro 9
Curitiba 8
Da Nang 8
Denver 8
Helsinki 8
Milan 8
Toronto 8
Washington 8
Belo Horizonte 7
Bologna 7
Falkenstein 7
Guarulhos 7
Johannesburg 7
Lappeenranta 7
Phoenix 7
Porto Alegre 7
Council Bluffs 6
Fisciano 6
Haiphong 6
Kochi 6
Kronberg 6
Ninh Bình 6
Wuhan 6
Bengaluru 5
Buenos Aires 5
Cairo 5
Dhaka 5
Düsseldorf 5
Guangzhou 5
Jeddah 5
Manchester 5
Marseille 5
Mumbai 5
Tashkent 5
Biên Hòa 4
Boydton 4
Brasília 4
Casablanca 4
Caserta 4
Caxias do Sul 4
Columbus 4
Dong Ket 4
Dublin 4
Formia 4
Hebei 4
Hải Dương 4
Totale 3.728
Salva come PNG Salva come JPEG
Nome #
Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection 142
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 136
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves 133
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 132
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 130
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 129
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study) 128
Indications to hospital admission and isolation of children with possible or defined tuberculosis: Systematic review and proposed recommendations for pediatric patients leaving in developed countries 128
Diabetes and COVID-19: The potential role of mTOR 124
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 122
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 121
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 120
Asunaprevir for hepatitis C: A safety evaluation 120
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 118
Does compulsory vaccination limit personal freedom? Ethical issues 118
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 118
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 114
Factors Affecting Outcome of Tuberculosis in Children in Italy: An Ecological Study 113
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 113
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 112
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 112
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study 111
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 111
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 110
Cytometric analysis of patients with COVID-19: what is changed in the second wave? 110
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)(BMC Infect Dis., (2024), 24, 1434, 10.1186/s12879-024-10303-5) 106
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 105
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge 105
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 105
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 105
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 105
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 104
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 104
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 104
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 103
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 102
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 101
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 101
The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study 101
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 101
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection 100
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 100
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 99
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 99
Chest CT in COVID-19 patients: structured vs conventional reporting 97
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 97
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 96
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series 95
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study (Journal of Neurology, (2022), 269, 6, (3301-3307), 10.1007/s00415-022-11009-x) 95
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 94
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results 92
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience 92
Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial 91
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 91
Update on the Management of Surgical Site Infections 90
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients 90
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 90
Recommendations for treating children with drug-resistant tuberculosis 90
Treatment of Carbapenem-Resistant Acinetobacter baumannii in Real Life (T-ACI): A Prospective Single-Center Observational Study 89
Effectiveness and Tolerability of Early Treatment with Monoclonal Antibodies against SARS-Cov-2: Results from A Real-Life Study before Omicron Surge 86
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 86
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 85
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience 83
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 81
Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study 79
Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy 74
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion 73
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 73
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort 50
Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy 43
Monoclonal antibodies against Clostridium difficile infection in the pipeline 39
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis 35
Totale 7.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 4 4 12 6 7 5
2021/2022197 3 2 1 0 0 13 2 10 14 21 53 78
2022/2023475 35 22 20 24 53 72 7 54 64 99 22 3
2023/2024470 17 65 76 38 40 79 3 43 13 6 48 42
2024/20252.417 70 41 11 46 69 140 239 154 164 283 954 246
2025/20263.391 553 477 636 588 873 230 34 0 0 0 0 0
Totale 7.251